AI and Ozempic: The two great disruptive tech...

On today’s episode, host Josh Christensen is joined by ‘Fast Company’ associate editor David Salazar to help break down the latest news in the world of business and innovation, including the fallout from DeepSeek’s LLM launch, the backtracked federal funding freeze, and the risin ...  Show more

Police departments across the country are embracing AI-enhanced surveillance technology in the name of stopping crime. One prominent security firm called Flock Safety is leading the effort and profiting off our fears. Fast Company Senior Writer Ainsley Harris joined Yaz and Josh ...  Show more

In the next two episodes of Your Undivided Attention, we take a close look at two respective industries: big food and social media, which represent dangerous “races to the bottom” and have big parallels with AI. And we are asking: what can our past mistakes and missed opportuniti ...  Show more

You asked, we answered. This has been a big year in the world of tech, with the rapid proliferation of artificial intelligence, acceleration of neurotechnology, and continued ethical missteps of social media. Looking back on 2023, there are still so many questions on our minds, a ...  Show more

Last year Novo Nordisk, the Danish pharmaceutical company behind Ozempic and Wegovy, overtook LVMH to become Europe’s most valuable company. And the pull for Acquired to finally tackle healthcare (18% of US GDP!) became too strong for us to resist. While we didn’t know much about ...  Show more

From Elon Musk to several Hollywood celebrities, the weight loss wonder drug, semaglutide, is taking the world by storm. What was an unintended consequence of a diabetes control med, the emergence of significant weight loss has raised the expectation of the wonder drug becomin ...